Minoza, Shemie P.

HRN: 24-51-10  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/25/2024
CEFUROXIME 1.5GM (VIAL)
01/25/2024
01/27/2024
IV
1.5grams
Q8hrs X 3 Doses
S/P Primary LTCS
Waiting Final Action 
01/25/2024
MUPIROCIN 2%, 15G (TUBE)
01/25/2024
01/31/2024
TOPICAL
15g
OD X 7 Days
S/P Primary LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: